ROBERT DETRINIS: Open Payments
NPI 1891734455 · DAPHNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 25 payments from 6 companies in 2025. Trend: 2023 $497 · 2024 $722 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $147 |
| Neurocrine BioSciences, Inc. | 4 | $117 |
| Alkermes, Inc. | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Lundbeck LLC | 1 | $21 |
Products named: COBENFY, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, UZEDY, REXULTI.
Industry payments across AL — which companies pay providers there.
